A Systematic Review of the Clinical Efficacy of Treatments in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Crossref DOI link: https://doi.org/10.1007/s12325-020-01507-7
Published Online: 2020-10-01
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thuresson, Per-Olof
Vander Velde, Nancy
Gupta, Palvi
Talbot, Jonathan
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd
Text and Data Mining valid from 2020-10-01
Version of Record valid from 2020-10-01
Article History
Received: 19 August 2020
Accepted: 14 September 2020
First Online: 1 October 2020